Company profile for Spiral Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

40 million people in the US qualify for hearing loss treatment, but there are no drugs approved for hearing loss. Drug delivery to the inner ear remains the largest obstacle. Precise, non-invasive placement techniques, combined with long-acting delivery systems have the potential to overcome the barriers of drug delivery to the inner ear. Inflammation and neurodegeneration are the origin of 90% of inner ear disorders. Biom...
40 million people in the US qualify for hearing loss treatment, but there are no drugs approved for hearing loss. Drug delivery to the inner ear remains the largest obstacle. Precise, non-invasive placement techniques, combined with long-acting delivery systems have the potential to overcome the barriers of drug delivery to the inner ear. Inflammation and neurodegeneration are the origin of 90% of inner ear disorders. Biomarkers of active disease and improved patient selection are necessary to overcome the challenges of clinical development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6000 Shoreline Ct, Suite 206, South San Francisco, CA 94080
Telephone
Telephone
+1 (650) 453-0893
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/spiral-therapeutics-announces-successful-completion-of-the-spt-2101-phase-1b2a-clinical-trial-for-menieres-disease-data-presented-during-the-2024-aao-annual-meeting-302262002.html

PR NEWSWIRE
30 Sep 2024

https://www.prnewswire.com/news-releases/spiral-therapeutics-to-present-at-the-barany-society-meeting-2024-302226575.html

PR NEWSWIRE
21 Aug 2024

https://www.prnewswire.com/news-releases/spiral-therapeutics-to-participate-at-the-2024-wedbush-pacgrow-healthcare-conference-302213661.html

PR NEWSWIRE
05 Aug 2024

https://www.prnewswire.com/news-releases/spiral-therapeutics-announces-collaboration-with-the-vestibular-disorders-association-veda-advancing-patient-centric-care-in-neurotology-301972364.html

PR NEWSWIRE
31 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty